Parexel maintained at underperform by Jefferies

Jefferies & Co. Inc. analyst David Windley maintained the underperform rating for Parexel International Corp. with a price target of $19 on the shares. Earnings per share may beat expectations due mostly to a declining tax rate. Jefferies wants to see a consistent narrowing of actual numbers versus management-provided guidance before changing its negative rating. Shares of the Waltham, Mass., biopharmaceutical company were up 12 cents, or 0.56%, at $21.37 on volume of 88,650 shares versus the three-month running average of 106,877 shares. (Nasdaq: PRXL)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.